Health knowledge and news provided by doctors.

Ads by Google

General Health

Genomic Health, Pfizer To Develop Prognostic Test For Non-Metastatic Renal Cell Carcinoma

Genomic Health, Pfizer to develop a genomic test to estimate the risk of recurrence following surgery for patients with Stage I-III renal carcinoma, clear cell type, that has not spread to other parts of the body.

Health and Wellness: